BVMF/G2ME34 (BVMF/G2ME34)

Brazil Stock Exchange: BVMF/G2ME34 · BRL

R$48.3

+0.00 (0.0%)· Recorded snapshot

Market cap	58.6B
Revenue (ttm)	16.3B
Net income (ttm)	2.8B
EPS (ttm)	R$2.61
P/E (trailing)	18.5x
P/E (forward)	15.5x
Volume	0
Beta	1.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.3B
Net income (ttm): 2.8B
EPS (ttm): R$2.61
P/E (trailing): 18.5x
P/E (forward): 15.5x
Market cap: 58.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E15.5

P25 n/aP50 n/aP75 n/a

Trailing P/E18.5

P25 n/aP50 n/aP75 n/a

ROE11.8

P25 n/aP50 n/aP75 n/a

ROIC13.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/G2ME34 indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-05
Employees	6,000
Employees change	700
Employees growth	13.21%
Enterprise value	BRL 54.7B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2003
Industry	Medical Devices
Is primary listing	No
ISIN number	BRG2MEBDR002
Last refreshed	2026-10-29
Market cap	BRL 58.6B
Next earnings date	2026-11-05
Price	BRL 48.34
Price currency	BRL
Sector	Healthcare
SIC code	3841
Stock price date	2026-09-14
Symbol	bvmf/G2ME34
Website	https://www.globusmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	46.32x
Average P/E ratio (3Y)	67.66x
Average P/E ratio (5Y)	56.33x
Earnings yield	5.41%
EV/Earnings	19.72x
EV/EBIT	13.94x
EV/EBITDA	9.81x
EV/FCF	13.97x
EV/Sales	3.24x
FCF / EV yield	7.16%
FCF yield	6.68%
Forward P/E	15.51x
Graham number	32.3814
Graham upside	-33.01%
Lynch fair value	BRL 54.46
Lynch upside	12.67%
P/(FCF - SBC) ratio	16.01x
P/(OCF - SBC) ratio	13.13x
P/B ratio	2.37x
P/E ratio	18.5x
P/FCF ratio	14.97x
P/OCF ratio	12.43x
P/S ratio	3.6x
Price / tangible book value	4.29x
Price/EBITDA ratio	11.2x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	23.22%
EBITDA margin	32.12%
Effective tax rate	18.89%
FCF margin	23.28%
Gross margin	68.98%
Operating margin	23.22%
Pretax margin	20.99%
Profit margin	17.03%
Profit per employee	BRL 462,327
Profitable quarters	9
Profitable years	17
Revenue per employee	BRL 2.7M
ROA	8.74%
ROA (5Y)	6.25%
ROCE	14.58%
ROE	11.81%
ROE (5Y)	7.76%
ROIC	13.93%
ROIC (5Y)	11.56%
SBC / revenue	1.56%
Tax / revenue	3.96%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	51.94%
EPS growth (Q)	-26.17%
EPS growth (QoQ)	22.22%
EPS growth 10Y	12.26%
EPS growth 3Y	25.03%
EPS growth 5Y	16.79%
EPS growth years	1
FCF growth	43.26%
FCF growth (Q)	464.08%
FCF growth (QoQ)	8.49%
FCF growth 3Y	84.12%
FCF growth 5Y	30.1%
Gross profit growth	23.08%
Gross profit growth (Q)	9.08%
Gross profit growth 3Y	38.67%
Gross profit growth 5Y	25.71%
Net income growth	50.13%
Net income growth (Q)	-25.28%
Net income growth (QoQ)	21.94%
Net income growth 3Y	37.86%
Net income growth 5Y	23.81%
Net income growth years	1
OCF growth	36.05%
OCF growth (Q)	169.37%
OCF growth (QoQ)	3.65%
OCF growth 10Y	19.53%
OCF growth 3Y	70.02%
OCF growth 5Y	28.86%
Operating income growth	57.45%
Operating income growth (Q)	51.36%
Operating income growth 3Y	43.37%
Operating income growth 5Y	26.41%
Revenue growth	19.74%
Revenue growth (Q)	5.94%
Revenue growth (QoQ)	3.92%
Revenue growth 10Y	18.96%
Revenue growth 3Y	42.06%
Revenue growth 5Y	27.65%
Revenue growth quarters	5
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -802M
Depreciation and amortization	BRL 1.5B
EBIT	BRL 3.8B
EBITDA	BRL 5.2B
EPS	BRL 2.61
Financing cash flow	BRL -700.1M
Free cash flow	BRL 3.9B
Free cash flow minus SBC	BRL 3.7B
Gross profit	BRL 11.2B
Income taxes	BRL 646M
Investing cash flow	BRL -2.6B
Net cash flow	BRL 1.4B
Net income	BRL 2.8B
Operating cash flow minus SBC	BRL 4.5B
Operating income	BRL 3.8B
Revenue	BRL 16.3B
Stock-based compensation	BRL 253.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	10.42
Book value per share	BRL 184.02
Debt / EBITDA	0.11
Debt / equity	0.02
Debt / FCF	0.15
Goodwill	BRL 7.7B
Long-term assets	BRL 16.6B
Long-term liabilities	BRL 1.2B
Net cash (debt)	BRL 3.8B
Net cash / market cap	6.44%
Net cash growth	574.39%
Net debt / EBITDA	-0.72
Net debt / equity	-0.15
Net debt / FCF	-0.96
Piotroski F-Score	7
Property, plant and equipment	BRL 3.2B
Shareholders' equity	BRL 24.7B
Tangible book value	BRL 13.7B
Tangible book value per share	BRL 101.79
Total assets	BRL 28.4B
Total cash	BRL 3.1B
Total debt	BRL 579.8M
Total liabilities	BRL 3.7B
WACC	10.16%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	BRL 11.8B
Current liabilities	BRL 2.6B
Current ratio	4.62
Inventory turnover	1.23
Net working capital	BRL 6B
Quick ratio	2.78
Working capital	BRL 9B
Working capital turnover	10.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.18%
Shareholder yield	1.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 52.41
1D price change	0%
1M price change	-7.04%
1M total return	-7.04%
1W price change	-7.04%
1W total return	-7.04%
1Y price change	22.32%
1Y return CAGR	22.34%
1Y total return	22.32%
20-day SMA	BRL 58.82
200-day SMA	BRL 52.64
50-day SMA	BRL 47.90
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 65.12
52-week high date	2026-01-08
52-week low	BRL 37.00
52-week low date	2025-09-24
6M price change	-17.38%
6M total return	-17.38%
All-time high	BRL 69.72
All-time high date	2025-01-30
All-time low	BRL 34.96
All-time low date	2022-06-21
Average true range (ATR)	BRL 2.70
Average volume	186.7
Beta (5Y)	1.09
Change from 52-week high	-25.77%
Change from 52-week low	30.65%
Change from all-time high	-30.67%
Change from all-time low	38.27%
Change from open	0%
Day's gap	0%
High price	BRL 48.34
Low price	BRL 48.34
Monthly RSI	50.56
Open price	BRL 48.34
Previous close	BRL 48.34
Price vs 150-day SMA	-7.77%
Price vs 20-day SMA	-17.82%
Price vs 200-day SMA	-8.17%
Price vs 50-day SMA	0.92%
Relative volume	0.01
RSI	40.77
Sharpe ratio	0.58
Sortino ratio	1.06
Volume	0
Weekly RSI	50.91
YTD price change	-21.78%
YTD total return	-21.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	110.9M
Shares change (QoQ)	-0.58%
Shares change (YoY)	-1.18%
Shares held by insiders	17.18%
Shares held by institutions	91.8%
Short ratio	5.8 days

Deeper analysis on BVMF/G2ME34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/G2ME34 report

Is a complete BVMF/G2ME34 research report available?

No complete published report is available for bvmf/G2ME34 (BVMF/G2ME34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/G2ME34 (BVMF/G2ME34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/G2ME34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/G2ME34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/G2ME34

Frequently asked questions